Knowledge of Pulmonary Neuroendocrine Tumors: Where Are We Now? Preface

被引：3
|
作者：
Filosso, Pier Luigi [1 ]
机构：
[1] Univ Turin, San Giovanni Battista Hosp, Dept Thorac Surg, I-10126 Turin, Italy
来源：
THORACIC SURGERY CLINICS | 2014年 / 24卷 / 03期
关键词：
INTERSTITIAL LUNG-DISEASE; SINGLE-CENTER-EXPERIENCE; CARCINOID-TUMORS; NEUROEPITHELIAL BODIES; PROGNOSTIC-FACTORS; CELL HYPERPLASIA; SYSTEM;
D O I：
10.1016/j.thorsurg.2014.05.005
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：IX / XII
页数：4
相关论文
共 50 条
  • [31] Visual analysis of lung neuroendocrine tumors based on CiteSpace knowledge graph
    Guo, Mingjie
    Hu, Shaowen
    Xiao, Yaifei
    Cao, Zhan
    Huang, Zhichao
    Liu, Yalong
    An, Xiaokang
    Zhang, Guoyu
    Zheng, Xianjie
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [32] Carbonic Anhydrase II Mediates Malignant Behavior of Pulmonary Neuroendocrine Tumors
    Zhou, Yuanxiang
    Mokhtari, Reza Bayat
    Pan, Jie
    Cutz, Ernest
    Yeger, Herman
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2015, 52 (02) : 183 - 192
  • [33] Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
    Caplin, M. E.
    Baudin, E.
    Ferolla, P.
    Filosso, P.
    Garcia-Yuste, M.
    Lim, E.
    Oberg, K.
    Pelosi, G.
    Perren, A.
    Rossi, R. E.
    Travis, W. D.
    ANNALS OF ONCOLOGY, 2015, 26 (08) : 1604 - 1620
  • [34] Radionuclide imaging of hypoxia: Where are we now? Special attention to cancer of the cervix uteri
    Mokoala, Kgomotso M. G.
    Lawal, Ismaheel O.
    Jeong, Jae Min
    Sathekge, Mike M.
    Vorster, Mariza
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2021, 24 (03) : 247 - 261
  • [35] Digital pathology in clinical use: where are we now and what is holding us back?
    Griffin, Jon
    Treanor, Darren
    HISTOPATHOLOGY, 2017, 70 (01) : 134 - 145
  • [36] Molecular Concepts of Immunomodulation for the Treatment of Metastatic Renal Cell Carcinomas: Where are We Now?
    Goebell, P. J.
    Bedke, J.
    AKTUELLE UROLOGIE, 2015, 46 (06) : 473 - 480
  • [37] Flipping the Script: Where Are We Now With Preoperative Radiation Therapy for Soft Tissue Sarcoma?
    Salerno, Kilian E.
    Tsang, Derek S.
    Braunstein, Steve E.
    Parkes, Jeannette D.
    Hiniker, Susan M.
    Ermoian, Ralph P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (03): : 615 - 620
  • [38] Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?
    Atilla, Erden
    Atilla, Pinar Ataca
    Demirer, Taner
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (03) : 257 - 264
  • [39] Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma: Where Are We Now and Which Way Should We Go?
    Le Gouill, Steven
    Mohty, Mohamad
    Guillaume, Thierry
    Gastinne, Thomas
    Moreau, Philippe
    SEMINARS IN HEMATOLOGY, 2011, 48 (03) : 227 - 239
  • [40] Co-expression of TTF-1 and neuroendocrine markers in the human fetal lung and pulmonary neuroendocrine tumors
    Miskovic, Josip
    Brekalo, Zdrinko
    Vukojevic, Katarina
    Miskovic, Helena Radic
    Kraljevic, Daniela
    Todorovic, Jelena
    Soljic, Violeta
    ACTA HISTOCHEMICA, 2015, 117 (4-5) : 451 - 459
12345